We are live on
!
Find out more
DCM
Deuterium Capital Management Portfolio holdings
AUM
$86M
1-Year Est. Return
87.31%
This Fund
S&P 500
This Quarter
Est. Return
+11.99%
1 Year Est. Return
+87.31%
3 Year Est. Return
+273.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$56.1M
AUM Growth
+$25.8M
(+85%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
39.23%
Top 10 Holdings %
Top 10 Hldgs %
73.49%
Holding
70
New
20
Increased
6
Reduced
2
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$11.1M |
| 2 |
Apple
AAPL
|
+$3.27M |
| 3 |
Monster Beverage
MNST
|
+$2.41M |
| 4 |
3M
MMM
|
+$1.18M |
| 5 |
NWLI
National Western Life Group, Inc. Class A
NWLI
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$881K |
| 2 |
Global X Uranium ETF
URA
|
+$546K |
| 3 |
UiPath
PATH
|
+$497K |
| 4 |
State Street SPDR S&P Homebuilders ETF
XHB
|
+$454K |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$410K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.71% |
| 2 | Healthcare | 14.23% |
| 3 | Energy | 5.9% |
| 4 | Consumer Staples | 5.29% |
| 5 | Industrials | 5.03% |
Similar funds
2C
AGC
VSCP
CI
CWM
APGDR
SAM
CAN
Deuterium Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Deuterium Capital Management held 70 positions worth $56.1M, up 85% from $30.3M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Deuterium Capital Management deployed $22M of net new capital in Q1 2024, opening 20 new positions and adding to 6 existing holdings. Its largest new stake was Oracle: 97,266 shares worth $12.2M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 38% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Global X Uranium ETF, an estimated $546K trimmed.
- Deuterium Capital Management's largest Q1 2024 buy was Oracle: 97,266 shares worth $12.2M.
- Deuterium Capital Management added most to Apple in Q1 2024, an estimated $3.27M increase.
- Deuterium Capital Management's biggest Q1 2024 reduction was Global X Uranium ETF, cutting an estimated $546K.
- Deuterium Capital Management fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $881K.
- Deuterium Capital Management's ten largest holdings make up 73% of its $56.1M portfolio in Q1 2024.
- Deuterium Capital Management opened 20 new positions and closed 14 in Q1 2024.
- Deuterium Capital Management's portfolio value rose 85% quarter-over-quarter to $56.1M.
Based on Deuterium Capital Management's 13F filing for Q1 2024, filed 6 May 2024.